Strategies for Optimized and Intensified Cell Culture Processes


Strategies for optimized and intensified cell culture processes



Presenter: Dr. Stefan R. Schmidt, Bioatrium | UPM Biomedicals 8th Annual Conference, 2022

Dr. Stefan R. Schmidt MBA currently serves as COO/Head of Operations at BioAtrium AG, a joint venture of Lonza and Sanofi in Visp, Switzerland. Previously he held the position as CSO and other senior executive roles at Rentschler Biopharma, Germany with overall responsibilities for biologics development and manufacturing. Before that, he was CSO at ERA Biotech in Barcelona, Spain, directing the company’s R&D efforts based on fusion proteins. Prior to that, he worked at AstraZeneca in Sweden where he led the unit of Protein Sciences within Global Protein Science & Supply as Associate Director. He started his leadership career 25 years ago at Biotech companies in Munich, Germany where he built up protein biochemistry teams for Connex and GPC-Biotech. He holds a PhD in Biochemistry from the Julius Maximilians University in Wuerzburg, Germany and a MBA from the University in Gävle, Sweden.